IFNG and cancer: Similarly, at high levels of IFNγ in inducible models producing ∼10 ng per ml (Huang et al., 2018), IFNγ acts on stromal cells independently of cancer cells to induce vascular regression and eliminate blood flow to tumors (Kammertoens et al., 2017).